Duke University publicizes that sublingual immunotherapy can treat life-threatening peanut allergy.

Dr. Wesely Burks, chief of the division of allergy and immunology in the department of pediatrics at Duke University Medical Center, was quoted and featured in an article in the Duke University newspaper, The Chronicle.  He and others are conducting studies in oral and sublingual immunotherapy that have made it possible for some children with once-fatal peanut allergies to safely consume peanut products. His subjects receive low doses of peanut daily—increasing from minute to larger doses over a period of years—that desensitize their immune systems to the consumption of peanuts. Some patients can tolerate between 10 and 20 peanuts after several months of treatment, Burks said.

http://dukechronicle.com/article/researcher-develops-immunotherapy-control-peanut-allergies